{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:24:56Z","timestamp":1775064296553,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.psychres.2020.113698","type":"journal-article","created":{"date-parts":[[2020,12,30]],"date-time":"2020-12-30T01:54:45Z","timestamp":1609293285000},"page":"113698","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Clozapine tolerability in Treatment Resistant Schizophrenia: exploring the role of sex"],"prefix":"10.1016","volume":"297","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8726-8023","authenticated-orcid":false,"given":"Francesca","family":"Martini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Spangaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariachiara","family":"Buonocore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margherita","family":"Bechi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Cocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmelo","family":"Guglielmino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacopo","family":"Sapienza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Agostoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Mastromatteo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Bosia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Cavallaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.psychres.2020.113698_bib0001","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2165\/00002018-200629070-00004","article-title":"Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles?","volume":"29","author":"Aichhorn","year":"2006","journal-title":"Drug Saf"},{"key":"10.1016\/j.psychres.2020.113698_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2019.112506","article-title":"A systematic review of sex-based differences in effectiveness and adverse effects of clozapine","volume":"280","author":"Alberich","year":"2019","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.psychres.2020.113698_bib0003","series-title":"Diagnostic and statistical manual of mental disorders","year":"2013"},{"issue":"9491","key":"10.1016\/j.psychres.2020.113698_bib0004","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome - A new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2020.113698_bib0005","series-title":"BioMed Research International","article-title":"Population Pharmacokinetics of Clozapine: A Systematic Review","author":"Albitar","year":"2020"},{"key":"10.1016\/j.psychres.2020.113698_bib0006","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12991-015-0075-x","article-title":"Sex differences in plasma clozapine and norclozapine concentrations in clinical practice and in relation to body mass index and plasma glucose concentrations: a retrospective survey","volume":"14","author":"Anderson","year":"2015","journal-title":"Ann Gen Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2020.113698_bib0007","doi-asserted-by":"crossref","first-page":"751","DOI":"10.4088\/JCP.09m05402yel","article-title":"Association of weight gain and metabolic syndrome in patients taking clozapine: an 8-year cohort study","volume":"72","author":"Bai","year":"2011","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2020.113698_bib0008","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/2045125315591917","article-title":"Factors predicting use of laxatives in outpatients stabilized on clozapine","volume":"5","author":"Bailey","year":"2015","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.psychres.2020.113698_bib0010","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s11682-017-9748-1","article-title":"Sexually divergent effect of COMT Val\/met genotype on subcortical volumes in schizophrenia","volume":"12","author":"Bollettini","year":"2018","journal-title":"Brain Imaging and Behavior"},{"issue":"3","key":"10.1016\/j.psychres.2020.113698_bib0011","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/hup.2223","article-title":"Plasma clozapine and norclozapine in relation to prescribed dose and other factors in patients aged 65 years and over: data from a therapeutic drug monitoring service, 1996-2010","volume":"27","author":"Bowskill","year":"2012","journal-title":"Human Psychopharmacology: Clinical and Experimental"},{"key":"10.1016\/j.psychres.2020.113698_bib0012","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fpsyt.2019.00067","article-title":"Predictive Factors of Treatment Resistance in First Episode of Psychosis: A Systematic Review","volume":"10","author":"Bozzatello","year":"2019","journal-title":"Front Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2020.113698_bib0013","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/JCP.0000000000000824","article-title":"Prevalence and Factors Associated with Clozapine-Related Constipation","volume":"38","author":"Chougule","year":"2018","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"3","key":"10.1016\/j.psychres.2020.113698_bib0015","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/YCO.0000000000000243","article-title":"Issues related to sex differences in antipsychotic treatment","volume":"29","author":"Crawford","year":"2016","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.psychres.2020.113698_bib0016","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ajp.2015.07.016","article-title":"Contribution of sex hormones to gender differences in schizophrenia: A review","volume":"18","author":"Silva","year":"2015","journal-title":"Asian J Psychiatr"},{"issue":"5","key":"10.1016\/j.psychres.2020.113698_bib0017","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/2042098618756261","article-title":"Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine","volume":"9","author":"De Berardis","year":"2018","journal-title":"Ther Adv Drug Saf"},{"issue":"1","key":"10.1016\/j.psychres.2020.113698_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41537-017-0043-3","article-title":"The effect of raloxifene augmentation in men and women with a schizophrenia spectrum disorder: a systematic review and meta-analysis","volume":"4","author":"De Boer","year":"2018","journal-title":"NPJ Schizophr"},{"issue":"1-2","key":"10.1016\/j.psychres.2020.113698_bib0019","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF02245621","article-title":"Effect of treatment duration on plasma levels of clozapine and N-desmethylclozapine in men and women","volume":"124","author":"Fabrazzo","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.psychres.2020.113698_bib0020","first-page":"105","article-title":"Therapeutic drug monitoring of clozapine and olanzapine. Similarities and differences","volume":"6","author":"Gaertner","year":"1999","journal-title":"Psychopharmakotherapie"},{"issue":"6","key":"10.1016\/j.psychres.2020.113698_bib0021","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00004714-199312000-00003","article-title":"Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking","volume":"13","author":"Hasegawa","year":"1993","journal-title":"J Clin Psychopharmacol"},{"issue":"7","key":"10.1016\/j.psychres.2020.113698_bib0022","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s00213-018-4881-0","article-title":"Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014","volume":"235","author":"Hollingworth","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.psychres.2020.113698_bib0023","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2174\/157488631002150515120209","article-title":"Prevalence of cardiovascular and metabolic events in patients prescribed clozapine: a retrospective observational, clinical cohort study","volume":"10","author":"Hyde","year":"2015","journal-title":"Curr Drug Saf"},{"issue":"3","key":"10.1016\/j.psychres.2020.113698_bib0024","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","article-title":"Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology","volume":"174","author":"Howes","year":"2017","journal-title":"The American journal of psychiatry"},{"issue":"7","key":"10.1016\/j.psychres.2020.113698_bib0025","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/08039488.2017.1334821","article-title":"Risk of diabetes and dyslipidemia during clozapine and other antipsychotic drug treatment of schizophrenia in Iceland","volume":"71","author":"Ingimarsson","year":"2017","journal-title":"Nord J Psychiatry"},{"issue":"7","key":"10.1016\/j.psychres.2020.113698_bib0026","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/08039488.2018.1517189","article-title":"Constipation, ileus and medication use during clozapine treatment in patients with schizophrenia in Iceland","volume":"72","author":"Ingimarsson","year":"2018","journal-title":"Nord J Psychiatry"},{"key":"10.1016\/j.psychres.2020.113698_bib0027","series-title":"The IDF consensus worldwide definition of the metabolic syndrome","year":"2005"},{"issue":"2","key":"10.1016\/j.psychres.2020.113698_bib0028","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.18com12123","article-title":"Clinical Guidance on the Identification and Management of Treatment-Resistant Schizophrenia","volume":"80","author":"Kane","year":"2019","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2020.113698_bib0029","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"issue":"2","key":"10.1016\/j.psychres.2020.113698_bib0030","first-page":"8","article-title":"Sex Differences in Antipsychotic Related Metabolic Functioning in Schizophrenia Spectrum Disorders","volume":"47","author":"Kraal","year":"2017","journal-title":"Psychopharmacol Bull"},{"issue":"15","key":"10.1016\/j.psychres.2020.113698_bib0031","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1017\/S0033291716002014","article-title":"Two distinct patterns of treatment resistance: Clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses","volume":"46","author":"Lally","year":"2016","journal-title":"Psychological Medicine"},{"issue":"4","key":"10.1016\/j.psychres.2020.113698_bib0032","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/14656566.2017.1288722","article-title":"How gender affects the pharmacotherapeutic approach to treating psychosis - a systematic review","volume":"18","author":"Lange","year":"2017","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"10.1016\/j.psychres.2020.113698_bib0033","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/JCP.0000000000000476","article-title":"Predicting Weight Gain in Patients Treated With Clozapine: The Role of Sex, Body Mass Index, and Smoking","volume":"36","author":"Lau","year":"2016","journal-title":"J Clin Psychopharmacol"},{"issue":"1-3","key":"10.1016\/j.psychres.2020.113698_bib0034","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.schres.2016.05.002","article-title":"Reasons for discontinuing clozapine: A cohort study of patients commencing treatment","volume":"174","author":"Legge","year":"2016","journal-title":"Schizophr Res"},{"issue":"6","key":"10.1016\/j.psychres.2020.113698_bib0035","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.mehy.2012.12.024","article-title":"Increasing the clozapine: norclozapine ratio with co-administration of fluvoxamine to enhance efficacy and minimize side effects of clozapine therapy","volume":"80","author":"L\u00e9gar\u00e9","year":"2013","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.psychres.2020.113698_bib0036","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.0065-1591.2000.0ap25.x","article-title":"Sex differences in schizophrenia, a review of the literature","volume":"401","author":"Leung","year":"2000","journal-title":"Acta psychiatrica Scandinavica. Supplementum"},{"key":"10.1016\/j.psychres.2020.113698_bib0037","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.2147\/NDT.S163839","article-title":"Influence of dose, gender, and cigarette smoking on clozapine plasma concentrations","volume":"14","author":"Mayerova","year":"2018","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"2","key":"10.1016\/j.psychres.2020.113698_bib0038","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/schbul\/sbr148","article-title":"Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders\u2013a systematic review and meta-analysis","volume":"39","author":"Mitchell","year":"2013","journal-title":"Schizophr Bull"},{"issue":"5","key":"10.1016\/j.psychres.2020.113698_bib0039","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/JCP.0b013e318267b3cd","article-title":"Predictors of clozapine response in patients with treatment-refractory schizophrenia: results from a Danish Register Study","volume":"32","author":"Nielsen","year":"2012","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.psychres.2020.113698_bib0040","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.schres.2018.03.017","article-title":"Persistent tachycardia in clozapine treated patients: A 24-hour ambulatory electrocardiogram study","volume":"199","author":"Nilsson","year":"2018","journal-title":"Schizophrenia Research"},{"issue":"3","key":"10.1016\/j.psychres.2020.113698_bib0041","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/s13311-017-0552-9","article-title":"Clozapine as a Model for Antipsychotic Development","volume":"14","author":"Nucifora","year":"2017","journal-title":"Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics"},{"issue":"JULY","key":"10.1016\/j.psychres.2020.113698_bib0042","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1192\/bjp.185.1.18","article-title":"Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders","volume":"185","author":"Perkins","year":"2004","journal-title":"British Journal of Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2020.113698_bib0043","first-page":"231","article-title":"Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients","volume":"148","author":"Perry","year":"1991","journal-title":"Am J Psychiatry"},{"issue":"8","key":"10.1016\/j.psychres.2020.113698_bib0044","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.ijporl.2015.05.010","article-title":"Drooling quantification: Correlation of different techniques","volume":"79","author":"Rashnoo","year":"2015","journal-title":"International journal of pediatric otorhinolaryngology"},{"issue":"9","key":"10.1016\/j.psychres.2020.113698_bib0045","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1080\/14740338.2016.1191468","article-title":"Clozapine's critical role in treatment resistant schizophrenia: ensuring both safety and use","volume":"15","author":"Remington","year":"2016","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"10.1016\/j.psychres.2020.113698_bib0046","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S2215-0366(16)30379-0","article-title":"Oestrogens, prolactin, hypothalamic-pituitary-gonadal axis, and schizophrenic psychoses","volume":"4","author":"Riecher-R\u00f6ssler","year":"2017","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2020.113698_bib0047","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00737-018-0847-9","article-title":"Sex and gender differences in schizophrenic psychoses-a critical review","volume":"21","author":"Riecher-R\u00f6ssler","year":"2018","journal-title":"Arch Womens Ment Health"},{"issue":"9","key":"10.1016\/j.psychres.2020.113698_bib0048","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s40263-017-0461-9","article-title":"Cardiovascular Disease in Clozapine-Treated Patients: Evidence, Mechanisms and Management","volume":"31","author":"Ronaldson","year":"2017","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.psychres.2020.113698_bib0049","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/medhum-2015-010734","article-title":"Gendering psychosis: the illness of Zelda Fitzgerald","volume":"42","author":"Seeman","year":"2016","journal-title":"Med Humanit"},{"key":"10.1016\/j.psychres.2020.113698_bib0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11126-018-9619-y","article-title":"Does Gender Influence Outcome in Schizophrenia?","volume":"90","author":"Seeman","year":"2019","journal-title":"Psychiatr Q"},{"key":"10.1016\/j.psychres.2020.113698_bib0051","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17060863","article-title":"Prevalence and predictors of Clozapine-associated constipation: A systematic review and meta-analysis","author":"Shirazi","year":"2016","journal-title":"International Journal of Molecular Sciences. MDPI AG."},{"issue":"4","key":"10.1016\/j.psychres.2020.113698_bib0052","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/NMD.0000000000000645","article-title":"Sex Differences in Psychiatric Hospitalizations of Individuals With Psychotic Disorders","volume":"205","author":"Shlomi Polachek","year":"2017","journal-title":"J Nerv Ment Dis"},{"issue":"1","key":"10.1016\/j.psychres.2020.113698_bib0053","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41537-020-0102-z","article-title":"The clinical course of schizophrenia in women and men-a nation-wide cohort study","volume":"6","author":"Sommer","year":"2020","journal-title":"NPJ schizophrenia"},{"issue":"11","key":"10.1016\/j.psychres.2020.113698_bib0054","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1517\/17425255.2015.1075003","article-title":"Pharmacogenetics of clozapine treatment response and side-effects in schizophrenia: an update","volume":"11","author":"Sriretnakumar","year":"2015","journal-title":"Expert opinion on drug metabolism & toxicology"},{"key":"10.1016\/j.psychres.2020.113698_bib0055","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.psychres.2019.01.110","article-title":"Reasons for clozapine discontinuation in patients with treatment-resistant schizophrenia","volume":"275","author":"Ucok","year":"2019","journal-title":"Psychiatry Research"},{"issue":"3","key":"10.1016\/j.psychres.2020.113698_bib0056","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.psychres.2006.09.016","article-title":"Gender differences in response to antipsychotic treatment in outpatients with schizophrenia","volume":"153","author":"Usall","year":"2007","journal-title":"Psychiatry Res"},{"issue":"4","key":"10.1016\/j.psychres.2020.113698_bib0057","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/YIC.0b013e32819f8f17","article-title":"Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration","volume":"22","author":"Yusufi","year":"2007","journal-title":"International clinical psychopharmacology"},{"key":"10.1016\/j.psychres.2020.113698_bib0058","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10182-007-0038-x","article-title":"STATISTICA Version 8.0. AStA Adv","volume":"91","author":"Weiss","year":"2007","journal-title":"Stat. Anal."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016517812033359X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016517812033359X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:43:13Z","timestamp":1759038193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016517812033359X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":56,"alternative-id":["S016517812033359X"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2020.113698","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clozapine tolerability in Treatment Resistant Schizophrenia: exploring the role of sex","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2020.113698","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113698"}}